Cargando…

CHL1 and NrCAM are Primarily Expressed in Low Grade Pediatric Neuroblastoma

BACKGROUND: Neural cell adhesion molecules like close homolog of L1 protein (CHL1) and neuronal glia related cell adhesion molecule (NrCAM) play an important role in development and regeneration of the central nervous system. However, they are also associated with cancerogenesis and progression in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wachowiak, Robin, Mayer, Steffi, Suttkus, Anne, Martynov, Illya, Lacher, Martin, Melling, Nathaniel, Izbicki, Jakob R., Tachezy, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972343/
https://www.ncbi.nlm.nih.gov/pubmed/31989042
http://dx.doi.org/10.1515/med-2019-0109
_version_ 1783489840819470336
author Wachowiak, Robin
Mayer, Steffi
Suttkus, Anne
Martynov, Illya
Lacher, Martin
Melling, Nathaniel
Izbicki, Jakob R.
Tachezy, Michael
author_facet Wachowiak, Robin
Mayer, Steffi
Suttkus, Anne
Martynov, Illya
Lacher, Martin
Melling, Nathaniel
Izbicki, Jakob R.
Tachezy, Michael
author_sort Wachowiak, Robin
collection PubMed
description BACKGROUND: Neural cell adhesion molecules like close homolog of L1 protein (CHL1) and neuronal glia related cell adhesion molecule (NrCAM) play an important role in development and regeneration of the central nervous system. However, they are also associated with cancerogenesis and progression in adult malignancies, thus gain increasing importance in cancer research. We therefore studied the expression of CHL1 and NrCAM according to the course of disease in children with neuroblastoma. METHODS: CHL1 and NrCAM expression levels were histologically assessed by tissue microarrays from surgically resected neuroblastoma specimens of 56 children. Expression of both markers was correlated to demographics as well as clinical data including metastatic dissemination and survival. RESULTS: CHL1 was expressed in 9% and NrCAM in 51% of neuroblastoma tissue samples. Expression of CHL1 was higher in patients with low Hughes grade 1a/b (p=0.01). NrCAM was more often detected in patients with a low International Staging System (INSS) score 1/2 (p=0.04). CONCLUSION: CHL1 and NrCAM expression was associated with low-grade pediatric neuroblastoma. These adhesion molecules may play a role in early tumor development of neuroblastoma.
format Online
Article
Text
id pubmed-6972343
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-69723432020-01-27 CHL1 and NrCAM are Primarily Expressed in Low Grade Pediatric Neuroblastoma Wachowiak, Robin Mayer, Steffi Suttkus, Anne Martynov, Illya Lacher, Martin Melling, Nathaniel Izbicki, Jakob R. Tachezy, Michael Open Med (Wars) Research Article BACKGROUND: Neural cell adhesion molecules like close homolog of L1 protein (CHL1) and neuronal glia related cell adhesion molecule (NrCAM) play an important role in development and regeneration of the central nervous system. However, they are also associated with cancerogenesis and progression in adult malignancies, thus gain increasing importance in cancer research. We therefore studied the expression of CHL1 and NrCAM according to the course of disease in children with neuroblastoma. METHODS: CHL1 and NrCAM expression levels were histologically assessed by tissue microarrays from surgically resected neuroblastoma specimens of 56 children. Expression of both markers was correlated to demographics as well as clinical data including metastatic dissemination and survival. RESULTS: CHL1 was expressed in 9% and NrCAM in 51% of neuroblastoma tissue samples. Expression of CHL1 was higher in patients with low Hughes grade 1a/b (p=0.01). NrCAM was more often detected in patients with a low International Staging System (INSS) score 1/2 (p=0.04). CONCLUSION: CHL1 and NrCAM expression was associated with low-grade pediatric neuroblastoma. These adhesion molecules may play a role in early tumor development of neuroblastoma. De Gruyter 2019-12-31 /pmc/articles/PMC6972343/ /pubmed/31989042 http://dx.doi.org/10.1515/med-2019-0109 Text en © 2019 Robin Wachowiak et al., published by De Gruyter http://creativecommons.org/licenses/by/4.0 This work is licensed under the Creative Commons Attribution 4.0 Public License.
spellingShingle Research Article
Wachowiak, Robin
Mayer, Steffi
Suttkus, Anne
Martynov, Illya
Lacher, Martin
Melling, Nathaniel
Izbicki, Jakob R.
Tachezy, Michael
CHL1 and NrCAM are Primarily Expressed in Low Grade Pediatric Neuroblastoma
title CHL1 and NrCAM are Primarily Expressed in Low Grade Pediatric Neuroblastoma
title_full CHL1 and NrCAM are Primarily Expressed in Low Grade Pediatric Neuroblastoma
title_fullStr CHL1 and NrCAM are Primarily Expressed in Low Grade Pediatric Neuroblastoma
title_full_unstemmed CHL1 and NrCAM are Primarily Expressed in Low Grade Pediatric Neuroblastoma
title_short CHL1 and NrCAM are Primarily Expressed in Low Grade Pediatric Neuroblastoma
title_sort chl1 and nrcam are primarily expressed in low grade pediatric neuroblastoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972343/
https://www.ncbi.nlm.nih.gov/pubmed/31989042
http://dx.doi.org/10.1515/med-2019-0109
work_keys_str_mv AT wachowiakrobin chl1andnrcamareprimarilyexpressedinlowgradepediatricneuroblastoma
AT mayersteffi chl1andnrcamareprimarilyexpressedinlowgradepediatricneuroblastoma
AT suttkusanne chl1andnrcamareprimarilyexpressedinlowgradepediatricneuroblastoma
AT martynovillya chl1andnrcamareprimarilyexpressedinlowgradepediatricneuroblastoma
AT lachermartin chl1andnrcamareprimarilyexpressedinlowgradepediatricneuroblastoma
AT mellingnathaniel chl1andnrcamareprimarilyexpressedinlowgradepediatricneuroblastoma
AT izbickijakobr chl1andnrcamareprimarilyexpressedinlowgradepediatricneuroblastoma
AT tachezymichael chl1andnrcamareprimarilyexpressedinlowgradepediatricneuroblastoma